GPX4 and cancer: In cancer therapy, direct inhibition of GPX4 is proposed as a superior strategy for inducing ferroptosis in cancer cells compared with disrupting GSH27, despite challenges such as poor selectivity and insufficient in vivo antitumor effects16,28,29.